Analysts: Aetna to Meet Targets and 3 New Opinions Investors Must Know Now

Cree Inc. (NASDAQ:CREE): According to Sterne Agee, Cree has tailwinds for further gross margin improvements that have not been adequately reflected in consensus estimates. The firm has decided to keep its Buy rating but raised its price target to $64 from $48 on the stock.

The stock market is roaring back in 2013. Click here now to discover winning stocks!